The Department of Defense offers funding for innovative early phase clinical trials or correlative studies aimed at improving prostate cancer clinical management. This grant supports interventions like drugs, devices, or surgical procedures and requires Investigational New Drug or Investigational Device Exemption approvals before application submission. The proposed studies should explore new concepts and offer scientific rationale for future larger trials in prostate cancer. Recipients are expected to initiate clinical trials within 12 months of the award date. Closing Date: August 23, 2012.
Opportunity ID: 156494
General Information
| Document Type:: | Grants Notice |
| Funding Opportunity Number:: | W81XWH-12-PCRP-CEA |
| Funding Opportunity Title:: | DoD Prostate Cancer Clinical Exploration Award |
| Opportunity Category:: | Discretionary |
| Opportunity Category Explanation:: | |
| Funding Instrument Type:: | |
| Category of Funding Activity:: | Science and Technology and other Research and Development |
| Category Explanation:: | |
| Expected Number of Awards:: | 3 |
| Assistance Listings Number(s):: | 12.420 — Military Medical Research and Development |
| Cost Sharing or Matching Requirement:: | No |
| Version:: | Synopsis 1 |
| Posted Date:: | Mar 20, 2012 |
| Last Updated Date:: | |
| Original Closing Date for Applications:: | Aug 23, 2012 |
| Current Closing Date for Applications:: | Aug 23, 2012 |
| Archive Date:: | Sep 22, 2012 |
| Estimated Total Program Funding:: | $ 2,200,000 |
| Award Ceiling:: | $0 |
| Award Floor:: | $0 |
Eligibility
| Eligible Applicants:: | Unrestricted (i.e., open to any type of entity above), subject to any clarification in text field entitled “Additional Information on Eligibility” |
| Additional Information on Eligibility:: |
Additional Information
| Agency Name:: | Dept. of the Army — USAMRAA |
| Description:: | Supports rapid execution of hypothesis-driven, early phase clinical trials or studies correlative to existing clinical trials to examine interventions that could have a major impact on prostate cancer clinical management. It is anticipated that proposed studies will explore innovative and untested concepts to provide scientific rationale or initial proof-of-principle for larger clinical trials in prostate cancer. Interventions may include drugs, devices, biologics, surgical procedures, behavior modifications, or other. Investigational New Drug or Investigational Device Exemption approvals, if applicable, must be in place before submission of the application. Clinical trials are expected to be initiated within 12 months of the award date. |
| Link to Additional Information:: | |
| Grantor Contact Information:: | If you have difficulty accessing the full announcement electronically, please contact: |
Version History
| Version | Modification Description | Updated Date |
|---|---|---|
| Synopsis 1 |
Package Status
Below are CLOSED Opportunity Package(s) no longer available for this Funding Opportunity:
Package No: 1
| Assistance Listings: | 12.420 |
| Competition ID: | |
| Competition Title: | |
| Opportunity Package ID: | PKG00108831 |
| Opening Date: | Mar 20, 2012 |
| Closing Date: | Aug 23, 2012 |
| Agency Contact Information:: | CDMRP Help Desk: 301-682-5507 |
| Who Can Apply:: | Organization Applicants |
| mendatory_forms |
SF424 (R & R) [V1.2] Project/Performance Site Location(s) [V1.4] Research & Related Budget [V1.1] Research And Related Senior/Key Person Profile (Expanded) [V1.2] Attachments [V1.1] |
| optional_forms | R & R Subaward Budget Attachment(s) Form 5 YR 30 ATT [V1.2] |
Packages
| Assistance Listings | Competition ID | Competition Title | Opportunity Package ID | Opening Date | Closing Date | Actions | Who Can Apply: | |
|---|---|---|---|---|---|---|---|---|
| 12.420 | PKG00108831 | Mar 20, 2012 | Aug 23, 2012 | View | CDMRP Help Desk: 301-682-5507 | Organization Applicants |